336 related articles for article (PubMed ID: 16712671)
1. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
2. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
3. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
[TBL] [Abstract][Full Text] [Related]
4. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
5. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
[TBL] [Abstract][Full Text] [Related]
6. Plasma apelin levels in subjects with nonalcoholic fatty liver disease.
Ercin CN; Dogru T; Tapan S; Kara M; Haymana C; Karadurmus N; Karslioglu Y; Acikel C
Metabolism; 2010 Jul; 59(7):977-81. PubMed ID: 20045153
[TBL] [Abstract][Full Text] [Related]
7. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
8. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
9. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
12. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
[TBL] [Abstract][Full Text] [Related]
13. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
15. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
[TBL] [Abstract][Full Text] [Related]
16. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
17. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP
Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343
[TBL] [Abstract][Full Text] [Related]
18. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
19. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
20. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
Hu ZW; Guo JW; Deng XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
